Scientists hunt for clues to stop dangerous drug allergies in kids with cancer
NCT ID NCT07499336
Summary
This study aims to understand why some children and young adults with acute lymphoblastic leukemia (ALL) develop severe allergic reactions to a key chemotherapy drug called PEG-asparaginase. Researchers will study the immune systems of 45 participants, comparing those who have a reaction to those who do not. The goal is to find biological markers that could predict who is at risk, potentially making future treatment safer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKAEMIA - CATEGORY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.